tiprankstipranks
TELA Bio (TELA)
NASDAQ:TELA
US Market

TELA Bio (TELA) Financial Statements

Compare
144 Followers

TELA Bio Financial Overview

TELA Bio's market cap is currently $48.85M. The company's EPS TTM is $-1.39; its P/E ratio is ―; TELA Bio is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 69.30M$ 58.45M$ 41.42M$ 29.46M$ 18.21M
Gross Profit$ 46.49M$ 40.11M$ 27.04M$ 18.81M$ 11.23M
Operating Income$ -34.12M$ -44.08M$ -39.01M$ -29.45M$ -25.27M
EBITDA$ -31.68M$ -40.63M$ -39.06M$ -29.14M$ -24.70M
Net Income$ -37.84M$ -46.66M$ -44.34M$ -36.11M$ -31.88M
Balance Sheet
Cash & Short-Term Investments$ 52.67M$ 46.73M$ 42.02M$ 43.93M$ 74.39M
Total Assets$ 86.57M$ 78.05M$ 67.86M$ 62.54M$ 86.46M
Total Debt$ 41.67M$ 41.08M$ 39.92M$ 31.49M$ 30.83M
Net Debt$ -11.00M$ -5.65M$ -2.10M$ -12.44M$ -43.57M
Total Liabilities$ 58.11M$ 59.17M$ 53.55M$ 42.45M$ 37.43M
Stockholders' Equity$ 28.46M$ 18.88M$ 14.30M$ 20.10M$ 49.03M
Cash Flow
Free Cash Flow$ -42.58M$ -41.47M$ -42.62M$ -31.06M$ -24.62M
Operating Cash Flow$ -41.59M$ -40.86M$ -40.75M$ -30.43M$ -24.46M
Investing Cash Flow$ 4.45M$ -599.00K$ -1.87M$ -627.00K$ 9.12M
Financing Cash Flow$ 43.06M$ 46.27M$ 40.85M$ 585.00K$ 44.41M
Currency in USD

TELA Bio Earnings and Revenue History

TELA Bio Debt to Assets

TELA Bio Cash Flow

TELA Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis